| abstract |
The invention relates to the application of a reagent for detecting the expression levels of H3K9me2, H3K9me3 and E-cadherin in the preparation of a liver cancer prognosis evaluation kit, so that the prognosis of liver cancer can be predicted, and the expression levels of H3K9me2, H3K9me3 and E-cadherin can be detected by immunohistochemical technology , so as to predict the prognosis of liver cancer, and the introduction of H3K9me2, H3K9me3 and E-cadherin is simple, the whole prediction and evaluation is simple and easy to implement, and the feasibility is high. |